Michael Ramon de Lima Conceição

Myocardial hypertrophy is prevented by farnesol through oxidative stress and ERK1/2 signaling pathways.

L. Quintans-Júnior, J. Cruz, L. Heimfarth, 2020, European journal of pharmacology.

Ranolazine exerts atrial antiarrhythmic effects in a rat model of monocrotaline‐induced pulmonary hypertension

D. Roman-Campos, Michael Ramon de Lima Conceição, Jorge Lucas Teixeira-Fonseca, 2023, Basic & clinical pharmacology & toxicology.

Commentaries on Viewpoint: Use aerobic energy expenditure instead of oxygen uptake to quantify exercise intensity and predict endurance performance.

D. Malatesta, T. Mickleborough, G. Howatson, 2018, Journal of applied physiology.

Evaluation of right atrium structure and function in a rat model of monocrotaline‐induced pulmonary hypertension: Exploring the possible antiarrhythmic properties of amiodarone

D. Roman-Campos, J. Joviano-Santos, Michael Ramon de Lima Conceição, 2023, Clinical and experimental pharmacology & physiology.

Exploring the involvement of TASK-1 in the control of isolated rat right atrium function from healthy animals and an experimental model of monocrotaline-induced pulmonary hypertension

D. Roman-Campos, Samuel Santos Beserra, L. Marques, 2023, Naunyn-Schmiedeberg's Archives of Pharmacology.

Extracellular acidification reveals the antiarrhythmic properties of amiodarone related to late sodium current-induced atrial arrhythmia.

L. Marques, Michael Ramon de Lima Conceição, Fabiana da Silva Alcântara, 2024, Pharmacological Reports.

Interaction of the antiarrhythmic drug Amiodarone with the sodium channel Nav1.5 depends on the extracellular pH.

Danilo Roman-Campos, L. Marques, Michael Ramon de Lima Conceição, 2023, European journal of pharmacology.